Evolent Health (NYSE:EVH) Given Buy Rating at Truist Financial

Truist Financial reiterated their buy rating on shares of Evolent Health (NYSE:EVH – Free Report) in a report issued on Tuesday, Benzinga reports. They currently have a $33.00 price target on the technology company’s stock. Other analysts also recently issued reports about the stock. Royal Bank of Canada reaffirmed an outperform rating and issued a […]

Leave a Reply

Your email address will not be published.

Previous post Shopify Inc. (TSE:SHOP) Senior Officer Sells C$251,027.59 in Stock
Next post Canaccord Genuity Group Raises Natera (NASDAQ:NTRA) Price Target to $145.00